Материал: Advanced Imaging of the Abdomen - Jovitas Skucas

FEMALE REPRODUCTIVE ORGANS

Posttherapy

Post–Hormone Therapy

Postmenopausal women are placed on estrogen therapy to lessen the osteoporosis or control ovarian atrophy. Because of an increased risk of endometrial hyperplasia and carcinoma with estrogen therapy alone, various regimens of progesterone are often added.

Endovaginal US in asymptomatic postmenopausal women after the initiation of hormone replacement therapy reveals an increased endometrial thickness after the start of therapy. Sequential hormone therapy leads to changes similar to a premenopausal endometrium. Endometrial thickness measured with endovaginal US in healthy women in physiologic menopause was 3.5mm, increasing to 5.7mm after estrogen therapy alone (117); after adding progestin, endometrial thickness measured 6.0mm. Endovaginal color Doppler US reveals that uterine artery PI and RI decrease during the first month of therapy.

Uterine artery pulsatility index in postmenopausal women receiving hormone replacement treatment tends to decrease, presumably due to increased uterine vascularity.

Some women develop vaginal bleeding while on hormonal therapy. Ultrasonography measurement of endometrial thickness does not select those who will bleed.

Postchemotherapy Changes

Tamoxifen citrate is a nonsteroidal antiestrogen agent binding to estrogen receptors and is used in breast cancer therapy. One of the side effects of tamoxifen is endometrial and myometrial stimulation and its use is associated with endometrial hyperplasia, polyps, and carcinomas. Fibromyomas also grow.

Endovaginal US found 69% of postmenopausal women treated with adjuvant tamoxifen to have an endometrial thickness >2.5mm (118). One recommendation is that an endometrial thickness of 6mm be considered a cutoff for endovaginal US in asymptomatic postmenopausal women receiving tamoxifen. A thickened, irregular, and hyperechoic endometrium containing small cysts or a homogeneous appearance is typical. Endovagi-

nal US using intrauterine saline as a contrast agent (hysterosonography) is more specific but not significantly more sensitive than endovaginal US in detecting endometrial abnormalities (119,120). Tamoxifen polyps tend to be larger than typical polyps and are composed of cystic glandular dilation, epithelial metaplasia, and periglandular stromal condensation (121). These polyps range from sessile to pedunculated and appear as a hyperechoic, smoothly marginated tumor. Some contain cysts. An irregular polyp outline or endometrial thickening should raise suspicion for a carcinoma.

Magnetic resonance imaging identifies two patterns in postmenopausal women with breast cancer receiving tamoxifen therapy (122):

1.A homogeneous hyperintense endometrium on T2-weighted images, postcontrast enhancement of the endometrialmyometrial junction, and a lumen signal void. Histopathology in two thirds of these women revealed either atrophic or proliferative endometria.

2.A heterogeneous endometrium on T2weighted images, postcontrast enhancement of the endometrial-myometrial junction, and lattice-like lumen enhancement, with most of these women having polyps.

Chemotherapy for breast cancer results in a loss of uterine volume, measurable with serial imaging.

Some investigators advocate routine US and endometrial biopsy even in asymptomatic women receiving tamoxifen. Hysteroscopy is used to resect any visualized polyps, and endometrial curettage evaluates abnormal endometrial thickening. An American College of Obstetricians and Gynecologists recommendation for women with breast cancer being treated with tamoxifen is to discontinue therapy if atypical hyperplasia is detected (121); a hysterectomy should be considered if further tamoxifen therapy is deemed necessary.

Postoperative Changes

One of the complications encountered with gynecologic surgery is ureteral damage. If damage is suspected, postoperative color Doppler US detection of ureteral jets is worth-

while, keeping in mind that it takes longer to visualize bilateral ureteral jets immediately after surgery.

Postlaparoscopy

The most common complication after laparoscopic gynecologic surgery is an incisional hernia. Omental herniation can occur through a trocar incision site.

Postoophorectomy

Occasionally ovarian remnants are left behind unintentionally after an oophorectomy. Some of these remnants are functional and lead to symptoms. Ultrasonography in women with ovarian remnants reveals a range from simple cysts, multiple septations, and presumed residual ovarian tissue with arterial and venous flow; aspiration of ovarian remnants provides symptomatic relief. Thus a US finding of a cystic or multiseptated pelvic mass containing a rim of vascular solid tissue, detected postoophorectomy, should raise the possibility of an ovarian remnant.

ADVANCED IMAGING OF THE ABDOMEN

Thus even complex fluid collections in a woman after hysterectomy do not necessitate antibiotic therapy or surgical drainage.

Imaging of the vaginal cuff shows a symmetric or slightly asymmetric soft tissue tumor, usually surrounded by fat. Sagittal US reveals the vaginal cuff as a hypoechoic linear structure with a thin central echogenic line. Unfortunately, a postoperative hematoma, seroma, abscess, or lymphocele also has a similar appearance, thus making detection of complications difficult. The presence of gas bubbles raises suspicion of an abscess.

Postoperative fibrosis is common. In general, MRI is superior to CT in detecting tumor recurrence, because MRI allows a distinction between fibrosis and tumor; fibrosis has a low signal intensity on T2-weighted images, while tumor has a high signal intensity.

Post-Laser Ablation of Endometrium

Laser endometrial ablation is performed to control symptomatic heavy, painful menses. Magnetic resonance imaging immediately after therapy reveals an increase in uterine volume due to endometrial swelling.

Poststerilization

Tubal sterilization is performed by ligation, occlusion with a clip or band, or by partial fallopian tube resection. Most of these obstructions are in the tube midportion and a postprocedure hysterosalpingogram reveals partial fallopian tube visualization.

Transcervical fallopian tube recanalization is achievable in most women. A successful pregnancy following recanalization, on the other hand, occurs in less than half. One complication of tubal recanalization is tubal perforation, usually associated with few, if any, sequelae.

Posthysterectomy

Hysterectomy-associated complications include pelvic abscess and injury to adjacent structures.

Endovaginal US commonly reveals pelvic fluid collections during the first postoperative week; these fluid collections gradually resolve and do not imply a postoperative complication.

Intrauterine Device Complications

An occasional intrauterine device migrates into the peritoneal cavity. Imaging or laparoscopy should localize it. One, inserted 4 years previously, migrated into the bladder and led to recurrent urinary tract infections (123); it was detected by US, conventional radiographs, and cystoscopy. These migrating devices tend to become surrounded by adhesions and thus are difficult to remove.

An intrauterine device was inserted through the urethra into the bladder (124); it could not be removed by transurethral endoscopy and required surgery.

Postradiation Therapy

Interstitial edema and inflammation of involved tissues develop shortly after radiation therapy. Magnetic resonance imaging during this phase reveals a hyperintense signal on T2-weighted

FEMALE REPRODUCTIVE ORGANS

images. Once fibrosis develops, after about 1 year, a hypointense signal predominates from the involved tissue and little postcontrast enhancement is evident.

Girls with Wilms’ tumors who underwent whole abdomen radiotherapy were later found to have primary ovarian failure (125); US revealed their ovaries to be undetected or small and their uteri to be abnormally small in spite of hormone replacement therapy. Ultrasonography in those who underwent hemiabdomen radiotherapy identified normal gonadotropin levels and a normal-sized uterus, but the ovary on the radiotherapy side was not seen or was small in half of the patients (125).

Chronic radiation changes consist primarily of fibrosis. Magnetic resonance imaging shows a low signal intensity on T2-weighted images. Postcontrast MR reveals tissue enhancement even during the chronic phase.

Examination and Surgical

Complications

Hysterosalpingography

Intravasation and subsequent embolization into the lungs are known complications of hysterosalpingography. The previously used oilbased media probably were less painful, but a number of embolization-associated deaths were reported. Therefore, most radiologists currently use water-soluble agents.

Tumor Seeding

Pelviscopic excision of malignant gynecologic tumors potentially disseminates malignant cells to surrounding structures. Localized tumor seeding or tumor dissemination develops intraperitoneally and at trocar sites after laparoscopic tumor resection. Most of these metastases are in patients with FIGO stages IIIC to IV, although even an ovarian mature cystic teratoma containing a focus of carcinoma poses a risk. Seeding occurs not only from malignant tumors; thus during laparoscopic myomectomy fragments of uterine leiomyomas were inadvertently implanted and grew in abdominal-wall incisions.

References

1.Valentini AL, Muzii L, Marana R, et al. Fallopian tube disease: the cobblestone pattern as a radiographic sign. Radiology 2000;217:521–525.

2.Spring DB, Barkan HE, Pruyn SC. Potential therapeutic effects of contrast materials in hysterosalpingography: a prospective randomized clinical trial. Kaiser Permanente Infertility Work Group. Radiology 2000; 214:53–57.

3.Alcazar JL, Errasti T, Zornoza A. Saline infusion sono-

hysterography in endometrial cancer: assessment of malignant cells dissemination risk. Acta Obstet Gynecol Scand 2000;79:321–322.

4.Yang WT, Yuen PM, Ho SS, Leung TN, Metreweli C. Intraoperative laparoscopic sonography for improved preoperative sonographic pathologic characterization of adnexal masses. J Ultrasound Med 1998; 17:53–61.

5.Hawighorst H, Bock M, Knopp MV, et al. Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiences. Magn Reson Imaging 1998;16:225–234.

6.Okada T, Harada M, Matsuzaki K, Nishitani H, Aono T. Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy. J Magn Reson Imaging 2001;13:912–917.

7.Buttram VC Jr, Gibbons WE. Müllerian anomalies: a proposed classification (an analysis of 144 cases). Fertil Steril 1979;32:40–46.

8.Sheih CP, Li YW, Liao YJ, Huang TS, Kao SP, Chen WJ. Diagnosing the combination of renal dysgenesis, Gartner’s duct cyst and ipsilateral mullerian duct obstruction. J Urol 1998;159:217–221.

9.Mevel O, Tahan H, Michel F. [Rupture of the female urethra in pelvic fractures: report of 2 cases.] [French] Prog Urol 2000;10:1212–1216.

10.Rao PM, Feltmate CM, Rhea JT, Schulick AH, Novelline RA. Helical computed tomography in differentiating appendicitis and acute gynecologic conditions. Obstet Gynecol 1999;93:417–421.

11.Godfrey H, Abernethy L, Boothroyd A. Torsion of an ovarian cyst mimicking enteric duplication cyst on transabdominal ultrasound: two cases. Pediatr Radiol 1998;28:171–173.

12.Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology 1999;210:209–216.

13.Varghese JC, O’Neill MJ, Gervais DA, Boland GW, Mueller PR. Transvaginal catheter drainage of tuboovarian abscess using the trocar method: technique and literature review. [Review] AJR 2001;177: 139–144.

14.Reyal F, Grynberg H, Sibony O, et al. [Pelvic actinomycosis: a case with secondary localization in the liver.] [French] Presse Med 1999;28:2098–2099.

15.Kirova YM, Feuilhade F, Belda-Lefrere MA, Le Bourgeois JP. Intrauterine device—associated pelvic actinomycosis: a rare disease mimicking advanced ovarian cancer: a case report. Eur J Gynaecol Oncol 1997;18:502–503.

16.Dykes TA, Isler RJ, McLean AC. MR imaging of Asherman syndrome: total endometrial obliteration. J Comput Assist Tomogr 1991;15:858–860.

17.Atri M, Chow CM, Kintzen G, et al. Expectant treatment of ectopic pregnancies: clinical and sonographic predictors. AJR 2001;176:123–127.

18.Chiang G, Levine D, Swire M, McNamara A, Mehta T. The intradecidual sign: is it reliable for diagnosis of early intrauterine pregnancy? AJR 2004;183:725–731.

19.Hertzberg BS, Kliewer MA, Bowie JD.Adnexal ring sign and hemoperitoneum caused by hemorrhagic ovarian cyst: pitfall in the sonographic diagnosis of ectopic pregnancy. AJR 1999;173:1301–1302.

20.Giambanco L, Chianchiano N, Palmeri V, Catalano G. [Cervical pregnancy: an obstetric emergency. A clinical case.] [Italian] Minerva Ginecol 1998;50: 321–324.

21.Jung SE, Byun JY, Lee JM, Choi BG, Hahn ST. Characteristic MR findings of cervical pregnancy. J Magn Reson Imaging 2001;13:918–922.

22.Ayaz T, Akansel G, Hayirlioglu A, Arslan A, Suer N, Kuru I. Ophthalmic artery color Doppler ultrasonography in mild-to-moderate preeclampsia. Eur J Radiol 2003;46:244–249.

23.Joern H, Funk A, Rath W. Doppler sonographic findings for hypertension in pregnancy and HELLP syndrome. J Perinat Med 1999;27:388–394.

24.Grannum PA, Berkowitz RL, Hobbins JC. The ultrasonic changes in the maturing placenta and their relation to fetal pulmonic maturity. Am J Obstet Gynecol 1979;133:915–922.

25.Kidney DD, Nguyen AM, Ahdoot D, Bickmore D, Deutsch LS, Majors C. Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation. AJR 2001;176:1521–1524.

26.Deux JF, Bazot M, Le Blanche AF, et al. Is selective embolization of uterine arteries a safe alternative to hysterectomy in patients with postpartum hemorrhage? AJR 2001;177:145–149.

27.Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995;86:775–779.

28.Lindheim SR, Cohen MA, Sauer MV. Ultrasound guided embryo transfer significantly improves pregnancy rates in women undergoing oocyte donation. Int J Gynaecol Obstet 1999;66:281–284.

29.Fleischer AC, Vasquez JM, Cullinan JA, Eisenberg E. Sonohysterography combined with sonosalpingography: correlation with endoscopic findings in infertility patients. J Ultrasound Med 1997;16:381–384.

30.Jain KA, Friedman DL, Pettinger TW, Alagappan R, Jeffrey RB Jr, Sommer FG. Adnexal masses: comparison of specificity of endovaginal US and pelvic MR imaging. Radiology 1993;186:697–704.

31.Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging—multivariate analysis. Radiology 2000;214: 39–46.

32.Hann LE, Lui DM, Shi W, Bach AM, Selland DL, Castiel M. Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation. Radiology 2000;216:242–247.

33.Rieber A, Nussle K, Stohr I, et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison

with transvaginal sonography, positron emission tomography, and histologic findings. AJR 2001;177: 123–129.

34.Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH. Characterization of adnexal mass lesions on MR imaging. AJR 2003;180:1297–1304.

35.Lee JH, Jeong YK, Park JK, Hwang JC. “Ovarian vascular pedicle” sign revealing organ of origin of a pelvic mass lesion on helical CT. AJR 2003;181:131–137.

36.Fedele L, Bianchi S, Portuese A, Borruto F, Dorta M. Transrectal ultrasonography in the assessment of rectovaginal endometriosis. Obstet Gynecol 1998;91:444– 448.

37.Bazot M, Darai E, Hourani R, et al. Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease. Radiology 2004;232:379– 389.

38.Tanaka YO, Yoshizako T, Nishida M, Yamaguchi M, Sugimura K, Itai Y. Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR 2000;175: 1423–1430.

39.Ko SF, Wan YL, Ng SH, et al. Adult ovarian granulosa cell tumors: spectrum of sonographic and CT findings with pathologic correlation. AJR 1999;172:1227–1233.

40.Conway C, Zalud I, Dilena M, et al. Simple cyst in the postmenopausal patient: detection and management. J Ultrasound Med 1998;17:369–372.

41.Chen CH, Tiu CM, Chou YH, Chen WY, Hwang B, Niu DM. Congenital hypothyroidism with multiple ovarian cysts. Eur J Pediatr 1999;158:851–852.

42.Lee HJ, Woo SK, Kim JS, Suh SJ. “Daughter cyst” sign: a sonographic finding of ovarian cyst in neonates, infants, and young children. AJR 2000;174:1013–1015.

43.Kikkawa F, Ishikawa H, Tamakoshi K, Nawa A, Suganuma N, Tomoda Y. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis. Obstet Gynecol 1997;89: 1017–1022.

44.Diebold J. [Molecular genetics of epithelial ovarian neoplasms: correlations with phenotype and biological behavior.] [Review] [German] Pathologe 1998;19: 95–103.

45.Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606–611.

46.Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities—report from the Radiological Diagnostic Oncology Group. Radiology 2000;215:761–767.

47.Ricke J, Sehouli J, Hach C, Hanninen EL, Lichtenegger W, Felix R. Prospective evaluation of contrastenhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol 2003;13:943–949.

48.Yoshida Y, Kurokawa T, Kawahara K, et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR 2004;182:227–233.

49.Yassa NA, Ryst E. Ovarian vein thrombosis: a common incidental finding in patients who have undergone total abdominal hysterectomy and bilateral salpingooophorectomy with retroperitoneal lymph node dissection. AJR 1999;172:45–47.

FEMALE REPRODUCTIVE ORGANS

50.Low RN, Saleh F, Song SY, et al. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination—a longitudinal study. Radiology 1999;211:519–528.

51.Funt SA, Hricak H, Abu-Rustum N, Mazumdar M, Felderman H, Chi DS. Role of CT in the management of recurrent ovarian cancer. AJR 2004;182:393–398.

52.Nakamoto Y, Saga T, Ishimori T, et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR 2001;176:1449–1454.

53.Cho SM, Ha HK, Byun JY, et al. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR 2002;179:391–395.

54.Method MW, Serafini AN, Averette HE, Rodriguez M, Penalver MA, Sevin BU. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report. Cancer 1996;77:2286–2293.

55.Sella T, Rosenbaum E, Edelmann DZ,Agid R, Bloom AI, Libson E. Value of chest CT scans in routine ovarian carcinoma follow-up. AJR 2001;177:857–859.

56.Dachman AH, Visweswaran A, Battula R, Jameel S, Waggoner SE. Role of chest CT in the follow-up of ovarian adenocarcinoma. AJR 2001;176:701–705.

57.O’Sullivan SG, Das Narla L, Ferraro E. Primary ovarian leiomyosarcoma in an adolescent following radiation for medulloblastoma. Pediatr Radiol 1998;28:468– 470.

58.Sugawara Y, Zasadny KR, Grossman HB, Francis IR, Clarke MF, Wahl RL. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Radiology 1999;211:249–256.

59.Morimura Y, Nishiyama H, Yanagida K, Sato A. Dysgerminoma with syncytiotrophoblastic giant cells arising from 46,XX pure gonadal dysgenesis. Obstet Gynecol 1998;92:654–656.

60.Yamaoka T, Togashi K, Koyama T, et al. Immature teratoma of the ovary: correlation of MR imaging and pathologic findings. Eur Radiol 2003;13:313–319.

61.Brown DL, Zou KH, Tempany CM, et al. Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study. Radiology 2001;219:213–218.

62.Jeong YY, Kang HK, Seo JJ, Nam JH. Luteinized fat in Krukenberg tumor: MR findings. Eur Radiol 2002;12 Suppl 3:S130–132.

63.Tjalma WA, Schatteman E, Goovaerts G,Verkinderen L, Van-den Borre F, Keersmaekers G. Adenocarcinoid of the appendix presenting as a disseminated ovarian carcinoma: report of a case. Surg Today 2000;30: 78–81.

64.Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases. J Exp Clin Cancer Res 2000;19:271–280.

65.Bakos O, Heimer G. Transvaginal ultrasonographic evaluation of the endometrium related to the histological findings in preand perimenopausal women. Gynecol Obstet Invest 1998;45:199–204.

66.Cohen MA, Sauer MV, Keltz M, Lindheim SR. Utilizing routine sonohysterography to detect intrauterine pathology before initiating hormone replacement therapy. Menopause 1999;6:68–70.

67.Shimizu M, Nakayama M. Endometrial ossification in a postmenopausal woman. J Clin Pathol 1997;50:171– 172.

68.Grasel RP, Outwater EK, Siegelman ES, Capuzzi D, Parker L, Hussain SM. Endometrial polyps: MR imaging features and distinction from endometrial carcinoma. Radiology 2000;214:47–52.

69.Siskin GP, Tublin ME, Stainken BF, Dowling K, Dolen EG. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. AJR 2001;177:297–302.

70.Jha RC, Takahama J, Imaoka I, et al. Adenomyosis: MRI of the uterus treated with uterine artery embolization. AJR 2003;181:851–856.

71.Tsuda H, Kawabata M, Nakamoto O,Yamamoto K. Clinical predictors in the natural history of uterine leiomyoma: preliminary study. J Ultrasound Med 1998;17: 17–20.

72.Caoili EM, Hertzberg BS, Kliewer MA, DeLong D, Bowie JD. Refractory shadowing from pelvic masses on sonography: a useful diagnostic sign for uterine leiomyomas. AJR 2000;174:97–101.

73.Torashima M, Yamashita Y, Matsuno Y, et al. The value of detection of flow voids between the uterus and the leiomyoma with MRI. J Magn Reson Imaging 1998; 8:427–431.

74.Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995;346:671–672.

75.Razavi MK, Hwang G, Jahed A, Modanloo S, Chen B. Abdominal myomectomy versus uterine fibroid embolization in the treatment of symptomatic uterine leiomyomas. AJR 2003;180:1571–1575.

76.Li W, Brophy DP, Chen Q, Edelman RR, Prasad PV. Semiquantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization. J Magn Reson Imaging 2000;12:1004– 1008.

77.Hagspiel KD, Matsumoto AH, Berr SS. Uterine fibroid embolization: assessment of treatment response using perfusion-weighted extraslice spin tagging (EST) magnetic resonance imaging. J Magn Reson Imaging 2001;13:982–986.

78.Katsumori T, Nakajima K, Mihara T. Is a large fibroid a high-risk factor for uterine artery embolization? AJR 2003;181:1309–1314.

79.Gabriel H, Pinto CM, Kumar M, et al. MRI detection of uterine necrosis after uterine artery embolization for fibroids. AJR 2004;183:733–736.

80.Vashisht A, Studd JW, Carey AH, et al. Fibroid embolisation: a technique not without significant complications. Br J Obstet Gynaecol 2000;107:1166– 1170.

81.Ryu RK, Siddiqi A, Omary RA, et al. Sonography of delayed effects of uterine artery embolization on ovarian arterial perfusion and function. AJR 2003;181: 89–92.

82.Pelage JP, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 2004;230: 803–809.

83.Burn PR, McCall JM, Chinn RJ, Vashisht A, Smith JR, Healy JC. Uterine fibroleiomyoma: MR imaging